SCHEMBL20428481

SCHEMBL20428481

C=COc1nc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)OC)cc3)nc2)[nH]c1-c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16660835 0.86 DGAT1 (0.79) DGAT1
SCHEMBL16787600 0.84 DGAT1 (1.00) DGAT1
SCHEMBL20428657 0.82 DGAT1 (0.82) DGAT1
SCHEMBL16660848 0.79 DGAT1 (0.85) DGAT1
SCHEMBL16648959 0.79 DGAT1 (0.80) DGAT1
SCHEMBL16787686 0.77 DGAT1 (0.65) DGAT1
SCHEMBL16660817 0.76 DGAT1 (0.69) DGAT1
SCHEMBL16790114 0.75 DGAT1 (0.73) DGAT1
SCHEMBL20428617 0.75 DGAT1 (0.56) DGAT1
SCHEMBL16787753 0.74 DGAT1 (0.75) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2862856-B1 IMIDAZOLE AND TRIAZOLE COMPOUNDS AS DGAT-1 INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2018-08-01 EP disclosed